ISSN: 2161-1017
Endocrinology & Metabolic Syndrome
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Sleep Debt and Postprandial Metabolic Function in Subclinical Cardiometabolic Pathophysiology

Barry E. Hurwitz*
Behavioral Medicine Research Center, University of Miami, Miami, USA
Corresponding Author : Barry E. Hurwitz
Behavioral Medicine Research Center
University of Miami, Clinical Research Building #777
1120 NW 14th Street, Miami
FL 33136, USA
Tel: 305-243-1444
Fax: 305-243-1445
Received June 14, 2012; Accepted June 15, 2012; Published June 17, 2012
Citation: Hurwitz BE (2012) Sleep Debt and Postprandial Metabolic Function in Subclinical Cardiometabolic Pathophysiology. Endocrinol Metab Synd 1:e107. doi:10.4172/2161-1017.1000e107
Copyright: © 2012 Shpakov AO. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google

Visit for more related articles at Endocrinology & Metabolic Syndrome

Compared with 4 decades ago, more than twice the adults (37%) are voluntarily restricting sleep from 8.5 hours to less than 7 hours per night [1-3]. Sleep curtailment has consequences that involve not just diminished daytime performance and enhanced sleepiness and fatigue [4], but may also facilitate disease mechanisms, manifesting in a high comorbidity of sleep dysfunction and subclinical cardiometabolic pathophysiology [5,6]. Indeed, epidemiological studies have linked chronic shortened and/or poor sleep with obesity [7,8], and then also with type 2 diabetes disease and cardiovascular [9-12]. Despite the attention of the health profession, the media, the public and mass educational campaigns about the benefits of healthier diets and increased physical activity, the prevalence of obesity in the United States has more than doubled over the past four decades [13,14]. This increasing prevalence constitutes a major public health challenge. In persons with obesity, cardiometabolic pathogenesis occurs prematurely, and is accelerated by factors that are likely to be a combination of the established risk factors, as well as underlying insulin and glucose metabolic dysfunction associated with prediabetes and metabolic syndrome (MetS) [15]. The impact of sleep curtailment on cardiometabolic processes has not been examined as a function of obesity, prediabetes, or MetS status. Sleep loss could contribute to the development of prediabetes and MetS by deleteriously affecting glycemic regulation and/or by influencing hunger, appetite, and feeding behavior and ultimately result in weight gain and obesity [5]. Evidence suggests that central obesity and insulin resistance may be central mediating pathways by which numerous biobehavioral factors, including sleep debt, drive subclinical cardiometabolic pathophysiology [16].
In our modern world, the frequency of meals and snacks is such that each day people are in an absorptive state for most of the hours that they are awake. A study of daily glycemic excursions in persons with type 2 diabetes underscores the potential contribution of postprandial assessment to the understanding of subclinical cardiometabolic pathophysiology [17]. In those with good glycemic control (i.e., HbA1c < 7%), broad glycemic variations throughout the day were observed, wherein up to 80% of these subjects displayed postprandial glucose values above 160mg/dl. Moreover, the correlations of postprandial glycemia with fasting glucose and HbA1c values were only moderate. These findings suggest that measures of postprandial glycemia may provide more information than is provided by each of the standard alternative glycemia measures. There is also considerable epidemiological evidence indicating that postprandial hyperglycemia, even in the absence of fasting hyperglycemia, is substantially predictive of increased CHD risk [18-22].
Recent evidence suggests that exposure of the circulatory system to repeated meal-induced waves of metabolic substances and their secondary products over the course of the day may accentuate vascular endothelial pathophysiology [23]. The pathway by which a carbohydrate meal or a high fat meal facilitates these deleterious processes is not yet fully understood but may include a mechanism by which postprandial glycemia, insulinemia, free fatty acids and/ or triglyceride rich lipids drive the production of proinflammatory cytokine release and oxygen radical species [24,25]. Research is needed to study postprandial processes longitudinally across days, weeks or longer, wherein interactive and compensatory metabolic processes may be more readily observed.
Animal studies have indicated that food deprivation results in a sleep duration decrement [26], whereas total sleep deprivation stimulates excessive feeding [27]. Most sleep deprivation research has focused on its detrimental effect on CNS functioning to the exclusion of peripheral systemic function [28]. However, the notion that sleep loss is linked with body weight, feeding behavior and comorbid prediabetes and MetS conditions has been supported by recent studies demonstrating that acute sleep curtailment in healthy individuals can result in severe metabolic and hormonal consequences and changes in hunger and appetite perception [29]. These studies have typically employed procedures to restrict sleep duration by about 4 hours per night for 2 to 6 consecutive nights [30]. Longer durations of curtailment typically result in more substantive effects, but the effects can be seen even with only 2 nights of sleep curtailment [28]. This relatively immature literature has employed simple within-subject designs, with small sample sizes usually restricted to men, and has not evaluated sleep curtailment in the context of cardiometabolic risk. Another relevant issue that has not been addressed to this point is the role of sleep debt chronicity and whether prolonged sleep debt manifests in a persistently exacerbated metabolic derangement or a compensatory metabolic normalization. In sum, although it appears that acute sleep loss impacts meal-related metabolic function deleteriously, further investigation is needed on the mediating influence of sleep debt and postprandial metabolic dysregulation on weight gain, obesity and subclinical cardiometabolic pathophysiology.
This report was supported by research grants (HL65668, HL081817) from the National Heart, Lung and Blood Institute of the National Institutes of Health.

Select your language of interest to view the total content in your interested language
Share This Article
Relevant Topics
Disc Adrenal Disorders
Disc Advanced Type 1 Diabetes Treatment
Disc Advanced Type 2 Diabetes Treatment
Disc Advances in Steroids Detection
Disc Advances in Steroids Treatment
Disc Advances of Diabetes Cure
Disc Anabolic Steroids
Disc Appetite
Disc Basal Metabolic Rate
Disc Behavioral Endocrinology
Disc Belly Fat
Disc Calcium Homeostasis
Disc Catabolic Steroids
Disc Cellular Endocrinology
Disc Childhood Diabetes
Disc Comparative Endocrinology
Disc Complications of Hyperglycemia
Disc Complications of Hypoglycemia
Disc Cortico Steroids
Disc Cortisol
Disc Diabetes
Disc Diabetes Cholestrol
Disc Diabetes Lipid Metabolism
Disc Diabetes Statistics
Disc Diabetes and Alcohol
Disc Diabetes and Weight Loss
Disc Diabetes for Dummies
Disc Endocrine Oncology
Disc Endocrine System Diseases
Disc Endocrinologist
Disc Endocrinologist Communication
Disc Endocrinology
Disc Endocrinology Case Reports
Disc Epidural Steroids
Disc Female Steroids
Disc Goiter
Disc Graves Disease
Disc Graves’ Disease
Disc Gyno Steroids
Disc Hashimoto's Thyroiditis
Disc Hormonal Disorders
Disc Hormonal Imbalance
Disc Hormonal Therapy
Disc Hormone Epinephrine
Disc Hydrocortisone
Disc Hyperthyroidism
Disc Hyperthyroidism Symptoms
Disc Hypothyroidism
Disc Hypothyroidism Symptoms
Disc Illegal Steroids
Disc Infertility
Disc Insulin Resistance
Disc Iodine Deficiency
Disc Iodine Supplements
Disc Latest Research on Diabetes
Disc Levothyroxine
Disc Liquid Steroids
Disc Menopause
Disc Metabolic Acidosis
Disc Metabolic Disorder
Disc Metabolic Nutrition
Disc Metabolic Pathway
Disc Metabolic Syndrome
Disc Metabolic Syndrome Diet
Disc Metabolic Weight Loss
Disc Metabolism
Disc Metabolism Boosters
Disc Nasal Steroids
Disc Neuro-Endocrinology
Disc Neuroactive steroids
Disc Obesity and Diabetes
Disc Oral Steroids
Disc Paediatric Endocrinology
Disc Parathyroid
Disc Parathyroid Hormone
Disc Pathophysiology of Diabetes
Disc Reverse Diabetes
Disc Sex Hormone
Disc Steroid Myopathy
Disc Steroid Transformation
Disc Steroids Addiction
Disc Steroids Supplements
Disc Steroids and Alcohol
Disc Steroids in Pregnancy
Disc Syndrome X
Disc Synthetic Steroids
Disc TSH Levels
Disc TSH Test
Disc Thyroid Cancer
Disc Thyroid Gland
Disc Thyroid Nodules
Disc Thyroid Symptoms
Disc Thyroid Test
Disc Thyroid Treatment
Disc Thyroidectomy
Disc Thyrotoxicosis
Disc Thyroxine
Disc Type 1 Diabetes
Disc Type 2 Diabetes
Disc Veterinary Steroids
Recommended Journals
Disc Journal of Diabetes & Metabolism
Disc Journal of Thyroid Disorders & Therapy
Disc Journal of Metabolic Syndrome
Disc Journal of Steroids & Hormonal Science
  View More»
Recommended Conferences
Disc 2nd Hormones and Steroids Conference
Jun 23-25, 2016, New Orleans, USA
Disc  2nd World Congress on Polycystic Ovarian Syndrome
October 05-07, 2016 Orlando, USA
Article Tools
Disc Export citation
Disc Share/Blog this article
Article usage
  Total views: 11128
  [From(publication date):
June-2012 - May 24, 2016]
  Breakdown by view type
  HTML page views : 7398
  PDF downloads :3730

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
OMICS International Conferences 2016-17
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

1-702-714-7001Extn: 9037

Business & Management Journals


1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

1-702-714-7001 Extn: 9042

© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version